$750K+ Strides Testosterone Gel Settlement Ends Class Action Lawsuit Over Alleged Benzene Contamination

New to ClassAction.org? Read our Newswire Disclaimer

Strides Pharma has agreed to a settlement of at least $750,000 to resolve a class action lawsuit that alleged the company manufactured and distributed testosterone gel containing benzene, a human carcinogen.

Don’t miss out on class action settlement news like this. Sign up for ClassAction.org’s free weekly newsletter.

The Strides class action settlement received preliminary approval from the court on May 21, 2026. The deal covers all natural individuals in the United States who purchased Strides testosterone gel for personal or household use between June 1, 2022 and July 31, 2025.

The court-approved website for the Strides testosterone gel settlement can be found at StridesGelSettlement.com. The website states that the Strides settlement covers approximately 95,000 people.

Strides settlement class members who file a valid, timely claim form can receive a cash payment from the deal. The amount of each class member’s payment will depend on when they purchased the product:

• For purchases made between January 1, 2025 and July 31, 2025, class members can receive 100 percent reimbursement for out-of-pocket payments for each prescription;
• For purchases made between January 1, 2024 and December 31, 2024, class members can receive 75 percent reimbursement for out-of-pocket payments for each prescription; and
• For purchases made between June 1, 2022 and December 31, 2023, class members can receive 40 percent reimbursement for out-of-pocket payments for each prescription.

Class members who incurred no out-of-pocket payments for prescriptions they purchased during the relevant time period can receive $3.50 per prescription, as modified by the aforementioned percentages based on purchase dates. The final value of each class member’s payout may be higher should the total value of all valid claims not reach the $750,000 amount.

Class members must provide sufficient proof, including pharmacy or insurance records and receipts, to receive a class action settlement payment.

The settlement website adds that, as part of the deal, Strides has reformulated its testosterone gel to “address the underlying issue” and has agreed to continued testing to ensure benzene-contaminated testosterone gel is not sold in the future.

To file a Strides settlement claim form, class members can head to this page and select whether they would prefer to file a claim form online or download a personalized claim form to print and return by mail to the settlement administrator.

All Strides testosterone settlement claim forms must be submitted online or by mail by September 16, 2026.

The court will determine whether to grant final approval to the Strides testosterone gel class action settlement following a hearing on November 19, 2026. Compensation will begin to be distributed to class members only after final approval is granted and any appeals are resolved.

The Strides class action lawsuit alleged that the pharmaceutical manufacturer failed to meet regulatory requirements because the testosterone gel was made with Carbomer 940, which contains benzene, and contained the carcinogen in excess of the applicable limit.

Check out ClassAction.org’s free legal resources to learn how to start a class action lawsuit.